Volume 91 Issue 12 | p. 35 | Concentrates
Issue Date: March 25, 2013

Chinese Herbal Medicine Compounds May Not Be Clues To Diabetes Treatments After All

Total synthesis of tatanans provides enough material to repeat biochemical tests of putative enzyme activators
Department: Science & Technology | Collection: Life Sciences
News Channels: Biological SCENE, Organic SCENE
Keywords: total synthesis, natural product, tatanan, type 2 diabetes, sigmatropic rearrangement, glucokinase

In the search for treatments of type 2 diabetes, scientists have been studying molecules that activate gluco­kinase. The enzyme catalyzes the first step in the human body’s breakdown of glucose and controls insulin secretion. In 2011, a trio of molecules named tatanans A–C that were purified from a traditional Chinese medicine attracted attention because they appeared to be the first natural products known to activate glucokinase. After completing the total synthesis of the tatanans, a team is now calling the original result into question (Nat. Chem., DOI: 10.1038/nchem.1597). Armen Zakarian and coworkers at the University of California, Santa Barbara, teamed with Brian G. Miller of Florida State University to take on the tatanans. They devised a 13-step route to tatanan A that used consecutive sigma­tropic rearrangements to set three adjacent chiral centers. They relied on a different approach to make tatanans B and C. When they repeated the 2011 experiments with human glucokinase and the synthesized tatanans, they saw no enzyme activation. It’s possible that another natural product was the glucokinase activator in the original study, the team speculates, and that it tagged along with the tatanans during isolation from the medicinal plant.

Chemical & Engineering News
ISSN 0009-2347
Copyright © American Chemical Society